Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Signori

Showing results (91-100 of 296) with videos related to

Pageof 30
Sort By:
Multiple Sclerosis and Related Disorders|August 31, 2023
Assessing the duration of EDSS improvement after a therapy start: A novel approach applied to the long-term extension of the PRISMS studyAlessio Signori, Francesca Bovis, Irene Schiavetti, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 30, 2020
Development and definition of a simplified scoring system in patients with multiple myeloma undergoing stem cells transplantation on standard computed tomography: myeloma spine and bone damage score (MSBDS)Alberto Stefano Tagliafico, Liliana Belgioia, Alessandro Bonsignore, et al.
Clinical Therapeutics|March 22, 2024
Explainable and Interpretable Machine Learning for Antimicrobial Stewardship: Opportunities and ChallengesDaniele Roberto Giacobbe, Cristina Marelli, Sabrina Guastavino, et al.
Frontiers in Oncology|July 1, 2022
Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung CancerEmilio Francesco Giunta, Alessio Signori, Howard Jack West, et al.
Journal of the American Heart Association|September 1, 2020
Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-AnalysisGiacomo Tini, Edoardo Bertero, Alessio Signori, et al.
Annals of Neurology|September 5, 2018
Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areasFrancesca Bovis, Alessio Signori, Luca Carmisciano, et al.
BMC Medicine|June 19, 2019
Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial dataFrancesca Bovis, Luca Carmisciano, Alessio Signori, et al.
Journal of Clinical Medicine|February 11, 2023
Role of Renal Parenchyma Attenuation and Perirenal Fat Stranding in Chest CT of Hospitalized Patients with COVID-19Elisa Russo, Alberto Stefano Tagliafico, Lorenzo Derchi, et al.
Technology in Cancer Research & Treatment|March 25, 2025
External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell CarcinomaMichele Maffezzoli, Alessio Signori, Davide Campobasso, et al.
Developmental Neuropsychology|September 6, 2017
Maturational Trajectory of Processing Speed Performance in Pediatric Multiple SclerosisNadine Akbar, Alessio Signori, Maria Pia Amato, et al.
Pageof 30

Showing results (91-100 of 296) with videos related to

Sort By:
Pageof 30
Multiple Sclerosis and Related Disorders|August 31, 2023
Assessing the duration of EDSS improvement after a therapy start: A novel approach applied to the long-term extension of the PRISMS studyAlessio Signori, Francesca Bovis, Irene Schiavetti, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|April 30, 2020
Development and definition of a simplified scoring system in patients with multiple myeloma undergoing stem cells transplantation on standard computed tomography: myeloma spine and bone damage score (MSBDS)Alberto Stefano Tagliafico, Liliana Belgioia, Alessandro Bonsignore, et al.
Clinical Therapeutics|March 22, 2024
Explainable and Interpretable Machine Learning for Antimicrobial Stewardship: Opportunities and ChallengesDaniele Roberto Giacobbe, Cristina Marelli, Sabrina Guastavino, et al.
Frontiers in Oncology|July 1, 2022
Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung CancerEmilio Francesco Giunta, Alessio Signori, Howard Jack West, et al.
Journal of the American Heart Association|September 1, 2020
Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-AnalysisGiacomo Tini, Edoardo Bertero, Alessio Signori, et al.
Annals of Neurology|September 5, 2018
Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areasFrancesca Bovis, Alessio Signori, Luca Carmisciano, et al.
BMC Medicine|June 19, 2019
Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial dataFrancesca Bovis, Luca Carmisciano, Alessio Signori, et al.
Journal of Clinical Medicine|February 11, 2023
Role of Renal Parenchyma Attenuation and Perirenal Fat Stranding in Chest CT of Hospitalized Patients with COVID-19Elisa Russo, Alberto Stefano Tagliafico, Lorenzo Derchi, et al.
Technology in Cancer Research & Treatment|March 25, 2025
External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell CarcinomaMichele Maffezzoli, Alessio Signori, Davide Campobasso, et al.
Developmental Neuropsychology|September 6, 2017
Maturational Trajectory of Processing Speed Performance in Pediatric Multiple SclerosisNadine Akbar, Alessio Signori, Maria Pia Amato, et al.
Pageof 30